The Valvular Interventions Center

Filter Your Results




PARTNER’s 2-Year Inoperable Cohort Data Support Edwards Sapien Valve

November 10, 2011—Edwards Lifesciences Corporation (Irvine, CA) announced 2-year results from the PARTNER trial’s cohort B, which was composed of 358 inoperable patients w…

FDA Approves Expansion of Edwards’ PARTNER II Trial

November 7, 2011—Edwards Lifesciences Corporation (Irvine, CA) announced that the US Food and Drug Administration (FDA) conditionally approved the addition of a second treat…

Medtronic’s CoreValve TAVI System Gains CE Mark for Direct Aortic Access

November 7, 2011—Medtronic, Inc. (Minneapolis, MN) announced that it has received CE Mark approval for the CoreValve system to be delivered by direct aortic access. The Core…

FDA Approves Edwards Sapien Transcatheter Aortic Valve

November 2, 2011—Edwards Lifesciences (Irvine, CA) announced that it has received approval from the US Food and Drug Administration (FDA) for transfemoral delivery of the Ed…

Edwards Accepts Most STS/ACC Recommended Restrictions for CMS Coverage of Sapien TAVR Device

November 2, 2011— reported online that Edwards Lifesciences (Irvine, CA) has accepted restrictions on its Sapien transcatheter heart valve for transcatheter aor…

Long-Term Outcomes from UK TAVI Registry Published

November 1, 2011—Neil E. Moat, MBBS, MS, et al published findings from the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry in the Journal of the Am…

Chief Medical Editor's Page: Transcatheter Valve Update

Ted E. Feldman, MD, FSCAI

September/October 2011—This month, we review the current status of some of the new structural and valve interventions. The issue is timely in the wake of the recent US Food and Drug Administratio…

PARTNER Trial Update

Jean-Michel Paradis, MD, and Susheel Kodali, MD

September/October 2011—An overview of the PARTNER trial and an update on the ongoing studies of transcatheter aortic valve replacement.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.